Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 125.65M | 98.21M | 148.72M | 136.36M | 261.77M |
Gross Profit | -19.03M | 18.43M | 56.84M | 21.16M | 92.58M |
EBITDA | -166.56M | -228.63M | -102.80M | -155.55M | -83.54M |
Net Income | -196.90M | -184.42M | -156.82M | -210.30M | -142.31M |
Balance Sheet | |||||
Total Assets | 555.88M | 840.64M | 1.02B | 1.17B | 1.24B |
Cash, Cash Equivalents and Short-Term Investments | 41.03M | 52.77M | 72.67M | 95.06M | 87.73M |
Total Debt | 361.00M | 371.20M | 367.23M | 347.08M | 251.49M |
Total Liabilities | 523.13M | 509.11M | 471.33M | 440.38M | 380.82M |
Stockholders Equity | 31.92M | 331.92M | 546.88M | 725.64M | 857.61M |
Cash Flow | |||||
Free Cash Flow | 5.16M | -8.75M | 6.69M | -70.03M | -63.00M |
Operating Cash Flow | 8.12M | 11.01M | 14.59M | -51.97M | -57.02M |
Investing Cash Flow | -8.48M | -7.30M | -3.35M | -35.57M | 54.20M |
Financing Cash Flow | -17.94M | -35.15M | -29.98M | 120.76M | -31.71M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $12.07B | 10.97 | 8.44% | 5.61% | -4.33% | -19.79% | |
76 Outperform | HK$129.83B | 22.22 | 22.73% | 3.80% | -17.53% | -8.90% | |
61 Neutral | $118.84B | 5.82 | 22.05% | 10.23% | 2.87% | ― | |
56 Neutral | C$5.98B | 5.15 | 45.71% | 3.55% | 10.68% | 8.23% | |
38 Underperform | HK$60.44M | ― | -323.09% | ― | -50.20% | 23.50% |